Stockhub

Cytosorbents Corporation: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

2 September 2022

  • curprev 02:3402:34, 2 September 2022 95.149.241.133 talk 2,093 bytes +2,093 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of per..."
Retrieved from "https://stockhub.co/research/Cytosorbents_Corporation"